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Abstract
The prevalence of testicular germ cell tumors (TGCT), a common solid tissue malignancy in young men, has been annually
increasing at an alarming rate of 3%. Since the majority of testicular cancers are derived from germ cells at the stage of
transformation of primordial germ cell (PGC) into gonocytes, the increase has been attributed to maternal/fetal exposures
to environmental factors. We examined the effects of an estrogen (diethylstilbestrol, DES), an antiandrogen (flutamide), or
radiation on the incidence of testicular germ cell tumors in genetically predisposed 129.MOLF-L1 (L1) congenic mice by
exposing them to these agents on days 10.5 and 11.5 of pregnancy. Neither flutamide nor DES produced noticeable
increases in testis cancer incidence at 4 weeks of age. In contrast, two doses of 0.8-Gy radiation increased the incidence of
TGCT from 45% to 100% in the offspring. The percentage of mice with bilateral tumors, weights of testes with TGCT, and the
percentage of tumors that were clearly teratomas were higher in the irradiated mice than in controls, indicating that
irradiation induced more aggressive tumors and/or more foci of initiation sites in each testis. This radiation dose did not
disrupt spermatogenesis, which was qualitatively normal in tumor-free testes although they were reduced in size. This is the
first proof of induction of testicular cancer by an environmental agent and suggests that the male fetus of women exposed
to radiation at about 5–6 weeks of pregnancy might have an increased risk of developing testicular cancer. Furthermore, it
provides a novel tool for studying the molecular and cellular events of testicular cancer pathogenesis.
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Introduction
Testicular germ cell tumors (TGCT) are the most common
malignant tumor in Caucasian men aged between 15 and 40
years. Human TGCTs are mainly classified histologically into
seminomas, which resemble the primordial germ cells (PGCs),
and non-seminomas, which are either undifferentiated (embryo-
nal carcinoma) or differentiated showing embryonic (teratoma)
or extra-embryonic (yolk sac) patterning [1]. Teratomas are
characterized by the differentiation to a diverse array of cell and
tissue types. The median age of onset of various tumor types
differs with seminomas arising at about 35 years, most non-
seminomas at 25 years, and most teratomas and yolk sac tumors
at around 1.5 years. Whereas the tumors appearing in adults are
preceded by carcinoma in situ (CIS), which contain cells closely
resembling gonocytes, those appearing in children are not
preceded by CIS [2]. In spite of these differences evidence
supports a common underlying pathogenesis of these tumors such
as similar chromosome aberrations, amplified chromosomal
regions, and expression of pluripotency genes [3]. All of these
tumors are derived from cells with characteristics of primordial
germ cells (PGC) or gonocytes, although at different stages of
development assessed by the extent of erasure of the original
biparental imprinting or the later establishment of paternal
imprinting.
There has been an annual increase of 3% in the incidence of
TGCTs in young Caucasian men throughout the world in the past
50 years [4], but the reasons are elusive. Elucidation of the cause
of this increase is important for possible prevention or reversal of
this increase.
Since testicular cancer cells are derived from primordial germ
cells (PGCs) or gonocytes [2] the increase has been attributed to
maternal and fetal exposures to environmental factors, with most
attention given to endocrine disruptors such as estrogens and
antiandrogens [5,6,7]. Ionizing radiation, a known carcinogen [8],
that increases the incidence of childhood and other adult cancers
in individuals exposed during fetal development [9,10], has
received little study. One case-control study did show that
exposure to ionizing radiation during pregnancy increased the
risk of testicular cancer in male offspring [11].
The only murine model for TGCT is the spontaneous
teratomas that were originally observed in 129/Sv mice [12].
They appear most similar to the infantile TGCTs in human
because germ cells rapidly develop into tumors after birth.
However, like all human TGCT types, the mouse teratomas also
originate from the PGCs or gonocytes. In addition, defects in the
same genes, kit-ligand (KITL) and Dmrt1, dramatically increase
the incidence of teratoma in mice [13,14] and are associated with
or predispose humans to the adult TGCTs [15,16]. These
examples suggest that this mouse teratoma model may be relevant
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there are reservations about such an extrapolation [1].
In the 129/Sv mice, about 3–10% develop spontaneous
TGCTs. Congenic mice on a 129 background have been
developed; those containing all of chromosome 19 derived from
the MOLF strain have an 80% incidence of TGCTs [17] and
those carrying portions of chromosome 19 display varying levels of
tumor incidence [18,19]. In the current study, we employed the
129.MOLF-L1 (L1) congenic strain, with a reported 30%
incidence of TGCTs, to maximize the power of the study. We
used this mouse model to test the effect of estrogen, antiandrogen
and ionizing radiation exposure on TGCT incidence. Exposures
were done at E10.5 and 11.5 which is just after the primordial
germ cells (PGCs) colonize the fetal gonad, and are undergoing
extensive epigenetic changes that suppress their potential to revert
to a pluripotent state and commit them to germ cell development
[20].
Results
We examined the effects of treatments with an estrogen
(diethylstilbestrol, DES), an antiandrogen (flutamide), or irradia-
tion on the incidence of TGCT in an animal model. We exposed
pregnant L1 females to the agents at days 10.5 and 11.5 of
pregnancy.
There was no effect of flutamide, DES or irradiation on the
reproductive ability of the dams (Table 1). This was confirmed by
the similar percentages of mice producing progeny after successful
mating and the comparable litter sizes in the treated and respective
control dams.
Testes were harvested from the male offspring and many of
them contained visible tumors (Figure 1A and B). Histological
examination confirmed that most of these were teratomas with
tissues from multiple dermal origins, but some contained only
neuroepithelial cells (Figure 1C and D). Flutamide did not
significantly increase the incidence of total TGCTs (30% of testes
had tumors vs. 21% in control). However, it did slightly increase
the incidence of TGCTs that were confirmed to be teratomas by
the presence of multiple dermal origin cell types (24% of testes vs.
14% in control, P=0.04) (Table 2).
The dose of DES given was effective in acting on the embryo as
it caused cryptorchidism in 16% of the testes. However, there was
no indication that it induced cancer (only 3 of 24 testes analyzed
contained TGCTs). Similarly in a study involving treatment of
pregnant 129 mice, a dose of ethinyl estradiol that increased
cryptorchidism in the offspring did not induce a significant change
in the incidence of teratomas [21].
In contrast, irradiation of the males during fetal development
with two doses, each of 0.8 Gy, led to TGCTs in 80% of the testes
(compared to 28% in control) and in 100% of the male offspring
(Table 2). The numbers of mice with unilateral and bilateral
tumors in all groups were binomially distributed, confirming a
previous report that the occurrence of a tumor in each testis was
an independent event [18]. The weights of testes with TGCTs and
the percentage of tumors that were confirmed teratomas were
higher in the irradiated mice than in controls, indicating that
irradiation induced more aggressive tumors and/or more foci of
initiation sites in each testis.
The two radiation doses of 0.8 Gy did not disrupt spermato-
genesis, which was qualitatively normal in testes that did not
contain teratoma (Figure 1E and F). However, these tumor-free
testes from irradiated mice had reduced weights compared to
those from controls (Table 2), suggesting that irradiation had
caused some loss or inhibition of proliferation of PGCs and/or
somatic cells.
Discussion
In the present study we unequivocally demonstrated that fetal
radiation exposure during E10.5–E11.5 induces testicular germ
Figure 1. Morphology and histology of the testes in 4-week-old
129.MOLF-L1 male mice irradiated in utero with two doses of
0.8 Gy and controls. Testicular morphology showing bilateral (A) and
unilateral (B) TGCTs from irradiated mice. Note that the testis without
TGCT after in utero radiation exposure (B) is smaller than the normal
untreated testis from a 4-week-old mouse (insert in B). Testis sections
showing teratoma containing tissues apparently from multiple dermal
origins identified by morphology (C), and TGCT containing only
neuroepithelial cells (NE) (D). CA: cartilage; BM: bone marrow; MS:
muscle, EEP: endodermal epithelium. ST: seminiferous tubule; BV: blood
vessel. Sections from testes of 4-week old irradiated (E) and contol (F)
mice without TGCT showing qualitatively normal spermatogenesis. Bar:
0.5 cm in A & B, and 50 mm in C–F.
doi:10.1371/journal.pone.0032064.g001
Table 1. Breeding efficiency in 129.MOLF-L1 congenic mice
with or without in utero flutamide, DES, or radiation
treatment.
Treatment Plug positive Produced progeny
a Litter size
b
Control 48 19 (40%) 4.960.3
Flutamide 36 23 (64%) 5.160.6
Control 5 3 (60%) 4.660.3
DES 12 6 (50%) 4.560.7
Control ND ND 6.460.7
Radiation 28 15 (54%) 5.360.6
aValues given as absolute number and percentage of total plug-positive
females.
bMean 6 SEM.
doi:10.1371/journal.pone.0032064.t001
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typical of teratomas, in a genetically susceptible mouse model.
This is the first demonstration of induction of testicular cancer by
an environmental agent when exposed during embryonic period.
Further characterization of the model to determine the optimal
exposure time or intervals, the dose-response, and the effects on
less susceptible mouse strains is needed to initiate mechanistic
studies and risk estimation.
Thefinding thatradiationdramaticallyincreasedthe incidenceof
testicular cancer in mice offers a new tool for investigating the
mechanism by which the PGCs revert to pluripotent embryonic
cells. When mouse PGCs arrive in the gonad at E10.5, they are
potentially pluripotent. However, by day 15.5, they are gonocytes
and have suppressed expression of pluripotency genes (Oct4, Nanog,
Sox2), undergone cell cycle arrest, are expressing germ cell genes
(Nanos3, Dazl, Dnd1, Mvh) [22,23], and are committed to the germ
cell self-renewal and differentiation pathway [12]. Between days
E10.5 & 11.5 they undergo epigenetic changes that include both
global DNA demethylation which involves single-strand breaks
(SSBs) and activation of the base-excision repair pathway with
chromatinlocalization of the proteins involved, as well as chromatin
remodeling involving loss and replacement of histones and changes
in their modifications [24]. Ionizing radiation itself induces larger
numbers of SSBs and produces damaged bases. This radiation-
induced damage might perturb signaling pathways involving
endogenousSSBs and base-excision repairregulating thisepigenetic
transformation and allow the cells to retain pluripotency as
embryonic stem-like cells that subsequently form the TGCTs.
Previously genetic alterations in germ cells, including the ter
mutation in the Dnd1 gene [25], loss of Dmrt1 [14], or loss of Pten [26]
produced a high incidence of TGCTs (particularly teratomas) in mice.
Analysis of the changes in expression of these genes or gene products
in PGCs and gonocytes of embryos of irradiated mice could elucidate
the mechanism by which radiation acts to induce the tumors.
Although the extrapolation of the teratomas in mice to the
sporadic testicular tumors in young adult human males is still
debatable, the present results on in utero irradiation of mice suggest
that the male fetus of women exposed to radiation at about 5–6
weeks of pregnancy might be at an increased risk of developing
testicular cancer. Cohort studies are unlikely to be able to test
whether there is an association between such exposure and testis
cancer since X-ray doses in diagnostic procedures have been
declining [9], the numbers of pregnant women in populations
exposed to radiation are small [10], there is likely a limited
developmental window of sensitivity, the incidence of testis cancer
in human is low, and several decades elapse between exposure and
appearance of tumors. Nevertheless, there is one report of an
association between maternal ionizing radiation exposure during
pregnancy and testicular cancer in their offspring [11]. The
knowledge gained about mechanisms of ionizing radiation-
induced testicular cancer in mice can be used to identify other
environmental or lifestyle factors that might cause similar damage
to fetal germ cells and be responsible for the current increases in
testicular cancer incidence in men.
Materials and Methods
Mice and breeding
A recently described inbred, congenic mouse strain, 129.MOLF-
L1 [19], referred to as L1 was used. These were originated from
crosses between the 129 (129S1/SvImJ) strain and MOLF/Ei inbred
mice of the Mus m. molossinus mouse subspecies. To create L1 mice
129 consomic mice with MOLF-Chr19 mice were backcrossed to
129, selecting for a 7.6 Mb region from the MOLF chromosome 19,
and then made homozygous for MOLF-derived region by
intercrossing the progeny. About 30% of the L1 males were reported
to develop spontaneous testicular tumors and the MOLF genes
contributing to this high tumor incidence are not yet known [19].
Timed matings were performed with pairs of L1 mice. Pregnant
females on days 10.5 and 11.5 of their pregnancy were treated
with two daily doses of the chemical or physical agent as described
below. In some cases females were used for a second or third
round of treatments during consecutive pregnancies with a waiting
period of a few weeks between pregnancies. In such cases of
multiple treatments, pregnant females received either the same
agent or they received control treatment in each pregnancy.
All experimental procedures were approved by the MD
Anderson Cancer Center Institutional Animal Care and Use
Committee with approved protocol numbers 110712631 and
110712632. All facilities for housing animals are registered by the
USDA and accredited by the American Association for the
Accreditation of Laboratory Animal Care.
Table 2. Testicular germ cell tumor (TGCT) incidence and related characterization in 129.MOLF-L1 congenic mice with or without
in utero flutamide, DES, or radiation treatment.
Treatment
No. males
analyzed
Overall TGCT
b
per mouse
Bilateral
TGCT
b per
mouse
No. testes
analyzed
TGCT
b per
testis
% identified
as teratomas
b
Weight (mg)
a testes
with no TGCT
Weight (mg)
a
testes with TGCT
Control 54 21 (39%) 2 (4%) 108 23 (21%) 15 (65%) 5061( n=8 4 ) 9 6 614 (n=22)
Flutamide 51 24 (47%) 7 (14%) 102 31 (30%) 27 (87%) 4961 (n=55) 109618 (n=25)
Control 5
c 1 (20%) 0 (0%) 10 1 (10%) 0 (0%) 4662 (n=9) 58 (n=1)
DES 12 2 (17%) 1 (8%) 24 3 (13%) 3 (100%) 4762
d (n=19) 161693 (n=3)
Control 20 9 (45%) 2 (10%) 40 11 (28%) 7 (64%) 6061( n=3 0 ) 7 6 69( n=1 0 )
Radiation 23 23 (100%)
e 14 (61%)
e 46 37 (80%)
e 35 (95%)
e 3661
f (n=9) 158628
f (n=37)
aMean 6 SEM.
bValues given as absolute number and percentage of mice, testes, or tumors analyzed.
cSince the incidence of tumors in the DES-treated mice was not increased from historical controls or the concurrent flutamide controls, we did not complete this arm of
the study, and cannot rigorously conclude that there is no increase in tumor incidence in DES-treated mice compared to a sham-treated control group.
dTwo cryptorchid testes (weights, 19 and 34 mg) were excluded from this average.
eSignificantly different between treated and control mice, Fisher’s exact Chi square test: P,0.01. Other differences were not significant (P$0.05).
fSignificantly different between treated and control mice, t test: P,0.01. Other differences were not significant (P$0.05).
doi:10.1371/journal.pone.0032064.t002
Induction of Testicular Cancer by Radiation
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e32064Treatments
Flutamide. Flutamide (Sigma Aldrich, St. Louis, MO),
dissolved in sesame oil/absolute ethanol (1:1), was given
subcutaneously as 2 doses of 40 mg/kg. This dose has been
shown to block androgen action in male mice [27] and is higher
than the human daily clinical oral dose of ,10 mg/kg.
Diethylstilbestrol (DES). DES (Sigma Aldrich, St. Louis,
MO), dissolved in corn oil, was given subcutaneously as two doses
of 5 mg/kg. Control pregnant mice received only the vehicle.
Based on a previous report [28], we performed initial experiments
with two doses of 20 mg/kg but reduced the dose after many of the
pregnant females failed to deliver offspring.
Radiation. Pregnant female L1 mice were irradiated with
Co
60-gamma radiation (Eldorado 8 radiation unit, Atomic Energy
of Canada Ltd., Ottawa, Canada). A maximum of 3 unanesthetized
mice at a time were placed in a ventilated methacrylate box
(4.1 cm611.7 cm68.2 cm) on a base of a minimum of 13 cm of
pressed wood, at a distance of 80 cm from the radiation source.
With a field size of 20620 cm, a dose of 0.8 Gy whole body
radiation was administered at 10–11 AM on days 10.5 and 11.5 of
pregnancy at a dose rate of about 70 cGy/min. The control L1
dams from the same breeding colony did not receive any of these
treatments or manipulations and the male offspring from these mice
were analyzed concurrently with those of the treated ones.
Analysis
The in utero exposed and control male offspring in the flutamide
armwere euthanized attheageof4–5 weeks; theexposed and control
males in the radiation and DES arms were euthanized at the age of 4
weeks. This time was chosen since tumors in L1 mice are visually
observed at these ages [19]. The testes were examined for the
presence of tumors by visual observation and then fixed in Bouin’s
solution for histologic examination. As some small tumors were not
evident by visual examination all tumors were identified by the
analysis of hematoxylin and eosin-stained 5-mms e c t i o n s .T u m o r s
with tissues from multipledermal types were recognized as teratomas.
Whenever, the initial testis section contained only cancerous
neuroepithelial cells, the blocks were re-sectioned to identify or rule
out the presence of other cancerous tissue types in other locations.
Statistical Analysis
The data are presented as mean 6SEM. The significance of
differences between the testis weights from mice of the same age
was evaluated by a Student’s t-test. The significance of the
differences in the frequency of TGCTs between treated and
control mice was determined using the Chi-square test.
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